Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guglielmo Bove

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Epigenetics|September 9, 2024
Epitranscriptomics and epigenetics: two sides of the same coin?Guglielmo Bove, Nunzio Del Gaudio, Lucia Altucci
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|February 3, 2022
OFD1: One gene, several disordersNunziana Pezzella, Guglielmo Bove, Roberta Tammaro, et al.
International Journal of Cancer|November 29, 2022
Interplay between m<sup>6</sup> A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectivesGuglielmo Bove, Sajid Amin, Mehrad Babaei, et al.
International Journal of Cancer|June 27, 2024
The m<sup>6</sup>A-independent role of epitranscriptomic factors in cancerGuglielmo Bove, Marco Crepaldi, Sajid Amin, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 26, 2022
Discovery of a new class of triazole based inhibitors of acetyl transferase KAT2ARoberta Pacifico, Nunzio Del Gaudio, Guglielmo Bove, et al.
Frontiers in Oncology|July 25, 2022
Looking Beyond the Glioblastoma Mask: Is Genomics the Right Path?Liliana Montella, Nunzio Del Gaudio, Guglielmo Bove, et al.
International Journal of Cancer|December 8, 2022
Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevanceLiliana Montella, Mariella Cuomo, Nunzio Del Gaudio, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 9, 2025
Unveiling New Triazoloquinoxaline-Based PROTACs Designed for the Selective Degradation of the ncBAF Chromatin Remodeling Subunit BRD9Martina Pierri, Guglielmo Bove, Erica Gazzillo, et al.
European Journal of Pharmacology|October 29, 2022
Efficacy of selective histone deacetylase 6 inhibition in mouse models of Pseudomonas aeruginosa infection: A new glimpse for reducing inflammation and infection in cystic fibrosisMargherita Brindisi, Simona Barone, Alice Rossi, et al.
Molecular Cancer|June 10, 2022
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathwayNunzio Del Gaudio, Antonella Di Costanzo, Ning Qing Liu, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Epigenetics|September 9, 2024
Epitranscriptomics and epigenetics: two sides of the same coin?Guglielmo Bove, Nunzio Del Gaudio, Lucia Altucci
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|February 3, 2022
OFD1: One gene, several disordersNunziana Pezzella, Guglielmo Bove, Roberta Tammaro, et al.
International Journal of Cancer|November 29, 2022
Interplay between m<sup>6</sup> A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectivesGuglielmo Bove, Sajid Amin, Mehrad Babaei, et al.
International Journal of Cancer|June 27, 2024
The m<sup>6</sup>A-independent role of epitranscriptomic factors in cancerGuglielmo Bove, Marco Crepaldi, Sajid Amin, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|July 26, 2022
Discovery of a new class of triazole based inhibitors of acetyl transferase KAT2ARoberta Pacifico, Nunzio Del Gaudio, Guglielmo Bove, et al.
Frontiers in Oncology|July 25, 2022
Looking Beyond the Glioblastoma Mask: Is Genomics the Right Path?Liliana Montella, Nunzio Del Gaudio, Guglielmo Bove, et al.
International Journal of Cancer|December 8, 2022
Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevanceLiliana Montella, Mariella Cuomo, Nunzio Del Gaudio, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|May 9, 2025
Unveiling New Triazoloquinoxaline-Based PROTACs Designed for the Selective Degradation of the ncBAF Chromatin Remodeling Subunit BRD9Martina Pierri, Guglielmo Bove, Erica Gazzillo, et al.
European Journal of Pharmacology|October 29, 2022
Efficacy of selective histone deacetylase 6 inhibition in mouse models of Pseudomonas aeruginosa infection: A new glimpse for reducing inflammation and infection in cystic fibrosisMargherita Brindisi, Simona Barone, Alice Rossi, et al.
Molecular Cancer|June 10, 2022
CBX2 shapes chromatin accessibility promoting AML via p38 MAPK signaling pathwayNunzio Del Gaudio, Antonella Di Costanzo, Ning Qing Liu, et al.
Pageof 2